|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Medical Game-Changers Beckonover 9 years ago
Investing in Africa: How to Do It Rightover 9 years ago
The Winning Edge in Emerging Marketsover 9 years ago
Paula Apsell: A Storied Life in Scienceover 9 years ago
Going to the Edgeover 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaover 9 years ago
Executive Pay and Innovationover 9 years ago
Science: The Communal Languagealmost 10 years ago
Will NICE ‘Go Commercial’?almost 10 years ago
Country Report: MexicoAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Pharmaceutical Executive Daily: Novartis and BMS Halt CAR-T Trials
3
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
4
Redefining Medical Strategy in Obesity Through Real-World iNSIGHTS
5